Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications

BACKGROUND: An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy or risks associated with PAC, guidelines are empiric or su...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelddal, Sarah, Nykjær, Karen Marie, Gregersen, Jon Waarst, Birn, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482554/
https://www.ncbi.nlm.nih.gov/pubmed/31023275
http://dx.doi.org/10.1186/s12882-019-1336-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482554/
https://www.ncbi.nlm.nih.gov/pubmed/31023275
http://dx.doi.org/10.1186/s12882-019-1336-8

Ejemplares similares